
Galderma has announced the launch of two phase 2 clinical trials evaluating its monoclonal antibody, nemolizumab, in two conditions: systemic …

Merck Serono and Galderma will be named in advertisements as guilty of the most serious breach of the ABPI Code …

Galderma has sensationally pulled out of the UK’s good conduct pact after the watchdog overseeing the ABPI Code found ‘extremely …

Allergan has been found guilty of breaching six clauses of the ABPI’s Code of Practice over its market research for …

AstraZeneca has signed a five-year deal with dermatology specialist Galderma Pharma to develop new treatments for conditions including psoriasis. It …
Dermatology specialist Galderma UK has appointed advertising agency Woolley Pau to work on a number of product launches. The agency …
The regional government in Québec in Canada is to contribute 10% of the costs of a new investment in manufacturing …